125 related articles for article (PubMed ID: 11266651)
1. Association of deletions and translocation of the reduced folate carrier gene with profound loss of gene expression in methotrexate-resistant K562 human erythroleukemia cells.
Ding BC; Witt TL; Hukku B; Heng H; Zhang L; Matherly LH
Biochem Pharmacol; 2001 Mar; 61(6):665-75. PubMed ID: 11266651
[TBL] [Abstract][Full Text] [Related]
2. Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells.
Worm J; Kirkin AF; Dzhandzhugazyan KN; Guldberg P
J Biol Chem; 2001 Oct; 276(43):39990-40000. PubMed ID: 11509559
[TBL] [Abstract][Full Text] [Related]
3. Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy.
Zhang L; Taub JW; Williamson M; Wong SC; Hukku B; Pullen J; Ravindranath Y; Matherly LH
Clin Cancer Res; 1998 Sep; 4(9):2169-77. PubMed ID: 9748136
[TBL] [Abstract][Full Text] [Related]
4. Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells.
Wong SC; Proefke SA; Bhushan A; Matherly LH
J Biol Chem; 1995 Jul; 270(29):17468-75. PubMed ID: 7615551
[TBL] [Abstract][Full Text] [Related]
5. Impaired membrane transport in methotrexate-resistant CCRF-CEM cells involves early translation termination and increased turnover of a mutant reduced folate carrier.
Wong SC; Zhang L; Witt TL; Proefke SA; Bhushan A; Matherly LH
J Biol Chem; 1999 Apr; 274(15):10388-94. PubMed ID: 10187828
[TBL] [Abstract][Full Text] [Related]
6. Gene amplification and increased expression of the reduced folate carrier in transport elevated K562 cells.
Wong SC; Zhang L; Proefke SA; Hukku B; Matherly LH
Biochem Pharmacol; 1998 Apr; 55(7):1135-8. PubMed ID: 9605439
[TBL] [Abstract][Full Text] [Related]
7. Transcript heterogeneity of the human reduced folate carrier results from the use of multiple promoters and variable splicing of alternative upstream exons.
Zhang L; Wong SC; Matherly LH
Biochem J; 1998 Jun; 332 ( Pt 3)(Pt 3):773-80. PubMed ID: 9620882
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of methotrexate resistance in osteosarcoma.
Guo W; Healey JH; Meyers PA; Ladanyi M; Huvos AG; Bertino JR; Gorlick R
Clin Cancer Res; 1999 Mar; 5(3):621-7. PubMed ID: 10100715
[TBL] [Abstract][Full Text] [Related]
9. Primary acute lymphoblastic leukemia cells use a novel promoter and 5'noncoding exon for the human reduced folate carrier that encodes a modified carrier translated from an upstream translational start.
Flatley RM; Payton SG; Taub JW; Matherly LH
Clin Cancer Res; 2004 Aug; 10(15):5111-22. PubMed ID: 15297414
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal localization of the murine RFC-1 gene encoding a folate transporter and its amplification in an antifolate resistant variant overproducing the transporter.
Roy K; Chiao JH; Spengler BA; Tolner B; Yang CH; Biedler JL; Sirotnak FM
Cancer Genet Cytogenet; 1998 Aug; 105(1):29-38. PubMed ID: 9689927
[TBL] [Abstract][Full Text] [Related]
11. Effects of the loss of capacity for N-glycosylation on the transport activity and cellular localization of the human reduced folate carrier.
Wong SC; Zhang L; Proefke SA; Matherly LH
Biochim Biophys Acta; 1998 Oct; 1375(1-2):6-12. PubMed ID: 9767079
[TBL] [Abstract][Full Text] [Related]
12. Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell lines.
Rothem L; Ifergan I; Kaufman Y; Priest DG; Jansen G; Assaraf YG
Biochem J; 2002 Nov; 367(Pt 3):741-50. PubMed ID: 12139489
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas.
Knobbe CB; Reifenberger J; Blaschke B; Reifenberger G
J Natl Cancer Inst; 2004 Mar; 96(6):483-6. PubMed ID: 15026474
[TBL] [Abstract][Full Text] [Related]
14. Repression of human reduced folate carrier gene expression by wild type p53.
Ding BC; Whetstine JR; Witt TL; Schuetz JD; Matherly LH
J Biol Chem; 2001 Mar; 276(12):8713-9. PubMed ID: 11106643
[TBL] [Abstract][Full Text] [Related]
15. Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines.
Moscow JA; Connolly T; Myers TG; Cheng CC; Paull K; Cowan KH
Int J Cancer; 1997 Jul; 72(1):184-90. PubMed ID: 9212241
[TBL] [Abstract][Full Text] [Related]
16. Confocal microscopy visualization of antifolate uptake by the reduced folate carrier in human leukaemic cells.
Jolivet J; Faure MP; Wong SC; Taub JW; Matherly LH
Br J Cancer; 1997; 76(6):734-8. PubMed ID: 9310238
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of multiple mechanisms of PT523 resistance in human leukemia cells harboring 3 reduced folate carrier alleles: transcriptional silencing, inactivating mutations, and allele loss.
Kaufman Y; Ifergan I; Rothem L; Jansen G; Assaraf YG
Blood; 2006 Apr; 107(8):3288-94. PubMed ID: 16368880
[TBL] [Abstract][Full Text] [Related]
18. Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells.
Ando T; Nishimura M; Oka Y
Leukemia; 2000 Nov; 14(11):1915-20. PubMed ID: 11069027
[TBL] [Abstract][Full Text] [Related]
19. Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier.
Yang R; Li WW; Hoang BH; Kim H; Banerjee D; Kheradpour A; Healey JH; Meyers PA; Bertino JR; Gorlick R
BMC Cancer; 2008 May; 8():124. PubMed ID: 18452618
[TBL] [Abstract][Full Text] [Related]
20. Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells.
Serra M; Reverter-Branchat G; Maurici D; Benini S; Shen JN; Chano T; Hattinger CM; Manara MC; Pasello M; Scotlandi K; Picci P
Ann Oncol; 2004 Jan; 15(1):151-60. PubMed ID: 14679136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
